200HO10955 POSITIVE

Print/PDF
Registration Name PROGENESIS POSITIVE
Registration Number HOCAN000012609140
Primary NAAB Code 200HO10955
Secondary Code(s) 777HO10955
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 10/6/2016
aAa 234156
DMS 234
GFI 12.7%
Genetic Codes * TV TD TL TY TR TC TP
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire S-S-I MONTROSS DUKE-ET
MGS EDG RUBICON-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 475, 95% R CM$ 489
NM Percentile 47% FM$ 439
GTPI 2942 GM$ 475
PRODUCTION TRAITS
9136 Dtrs 1951 herds 34 % US 99% R
Milk 874 Fat, % 85 , +0.18%
SCS 3.11, 99% R Protein, % 38 , +0.03%
Feed Saved 42 , 73% R Milking Speed 7.09 , 97% R
Health & Fertility
Productive Life -1.1      99% R Mastitis -0.9      98% R
Heifer Livability -1.0       94% R Metritis -0.2      96% R
Livability -3.0      97% R D. Abom 0.0      97% R
DPR -2.0      99% R Ketosis 0.2      95% R
FSC -2.4      99% R R. Placenta 0.4      97% R
HCR -1.4      98% R Milk Fever 0.0      92% R
CCR -2.1      99% R
SCR -        -
DIA -2.1      84% R
RSP -2.5      93% R
Calving Traits
Sire CE 1.5      99% R 12155 Obs
Daughter CE 1.7      98% R 2869 Obs, 5576 Dtrs
Sire SB 3.5      98% R 12780 Obs
Daughter SB 4.1      98% R 2672 Obs, Dtrs
Gestation Length 0.0      99% R 228 Obs, 4464 Dtrs
Early First Calving -2.6      99% R 314 Obs, 2516 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
5016 Dtrs 1358 herds 99% R
PTA Type 0.68 UDC 1.13
HCC 0.44 BWC -0.74
FLC -0.48
Linear Traits
Stature 0.22
Tall
Strength 0.01
Strong
Body Depth 0.39
Deep
Dairy Form 1.89
Open
Rump Angle 2.82
Sloped
Thurl Width 0.36
Sloped
Rear Legs-Side View 0.36
Wide
Rear Legs-Rear View -0.93
H.-in
Foot Angle -0.45
Low
Feet & Legs Score -0.22
Low
F.U. Attachment 0.74
Curved
Rear Udder Height 1.35
High
Rear Udder Width 2.39
Wide
Udder Cleft -0.13
Weak
Udder Depth -0.93
H.-in
Front Teat Placement 1.51
Close
Rear Teat Placement 1.31
Close
Teat Length -2.23
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO